A Study of NGM282 in Patients With Primary Sclerosing Cholangitis

NCT02704364 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Sclerosing Cholangitis

Interventions

BIOLOGICAL: NGM282
OTHER: Placebo

Sponsor

NGM Biopharmaceuticals, Inc